medical biomaterial News
-
Endomedix publishes ground breaking research and method development for the use of biologically derived polysaccharides in implantable medical devices in peer reviewed journal
Endomedix, Inc. announced today the first of a series of publications of its research and patented technology for a new family of biomaterials based on natural polysaccharides. Appearing in the Journal of Applied Polymer Science, the article, “Reproducible, biocompatible medical materials from biologically derived polysaccharides: Processing and Characterization”, addresses the ...
-
Withdrawn Standard: ASTM F1251-89(2003) Standard Terminology Relating to Polymeric Biomaterials in Medical and Surgical Devices (Withdrawn 2012)
This terminology covers polymeric biomaterials in medical and surgical devices. Terms are defined as they are used relative to medical and surgical materials and devices. Terms that are generally understood and in ...
-
Heraeus Opens New PV Facility in Taiwan
The Heraeus Photovoltaics Business Unit has announced the opening of its newest manufacturing site in Taiwan. The facility will allow Heraeus PV to offer faster service and customized products for the Taiwanese market. The expansion of the Taiwan facility establishes Heraeus' dedication to the region and the PV industry with plans for continued growth. "Taiwan is an important market for ...
By Heraeus
-
Defymed at the conference of the European Society for Biomaterials
September 5th-9th: Defymed at the conference of the European Society for Biomaterials Last year Defymed attended for the first time to the World Biomaterials Congress which held on December 11-15, 2020 via an excellent virtual platform. This year Defymed confirms its strong interest on biomaterials, improvement performed to process them and how they could be used in conjunction with other ...
By Defymed
-
STEMart Launches Pyrogenicity Testing Service for Medical Devices
STEMart, a provider of integrated medical device CRO services dedicated to medical device and diagnostic clinical development, now launches Pyrogenicity Testing service for the medical device industry. This new testing follows the biocompatibility guidelines modified for medical devices. Due to the risks associated with medical devices, comprehensive medical device testing throughout the product ...
By STEMart
-
Healionics Awarded SBIR Contract from DOD to Develop Biointegrated Synthetic Vascular Graft
Healionics Corporation has been awarded a $150,000 Small Business Innovation Research (SBIR) contract from the Department of Defense (DOD) to demonstrate feasibility for an improved vascular graft design. Andrew Marshall, PhD, Healionics’ Chief Technology Officer, is the Principal Investigator for this research project. Titled, “Biointegrated Synthetic Grafts for Vascular ...
By Healionics
-
Healionics’ Vascular Access Device Featured at American Society of Nephrology’s Kidney Week 2016
Healionics’ STARport HD, a novel preclinical stage implantable device that allows needle-free bloodstream access for hemodialysis treatment, has been selected by the American Society of Nephrology (ASN) to be featured at the ASN exhibit booth at Kidney Week 2016 as one of several new technologies portraying the future of kidney disease treatment. Kidney Week 2016 is the 50th annual kidney ...
By Healionics
-
Healionics Receives SBIR Grant from National Institutes of Health to Develop Needle Free Dialysis Access Devices
Healionics Corporation has received a $224,500 Small Business Innovation Research (SBIR) grant award from the National Institute of Diabetes and Digestive and Kidney Diseases division of the National Institutes of Health (NIH) for preclinical studies to develop a novel vascular graft for use with needle-free hemodialysis access ports. Andrew Marshall, PhD, Healionics’ Chief Technology ...
By Healionics
-
Second Patent Issued for Healionics’ Textured STAR Biointerface
Healionics Corporation has received a further patent for its textured STAR Biointerface technology. The United States Patent and Trademark Office issued Patent No. 8,647,393, "Implantable Medical Devices Having Microporous Surface Layers and Method for Reducing Foreign Body Response to the Same.” This new patent extends the scope of 8,372,423 issued to Healionics in February 2013. The STAR ...
By Healionics
-
T,C&A Lab Declares Capability of Biomedical Materials Testing
Since the last few decades, biomedical materials have been extensively used in a lot of medical applications, such as tissue scaffolds, wound care, regenerative dentistry, bone graft, implantable devices and cosmetic surgery. Earlier this month, T,C&A Lab, a branch of Alfa Chemistry, announces to provide biomedical material testing service for customers worldwide who would like to ensure ...
-
Healionics Announces New CEO
Healionics Corporation, a Seattle-based medical device company, today announced the appointment of Mike Connolly as Chief Executive Officer. Connolly brings 25 years of leadership in the medical device industry including extensive experience in both operating and venture investing roles. “We are fortunate to add a leader of Mike’s caliber,” said Andrew Marshall, Director and ...
By Healionics
-
Healionics Awarded $1.5M SBIR Grant from NIH to Advance Clot-Resistant Synthetic Vascular Graft for Dialysis Patients
Healionics Corporation, a Seattle-based medical device company, was awarded a $1.5M Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) to develop new vascular grafts for dialysis use that overcome the major problem of clotting failure. Andrew Marshall, Ph.D., ...
By Healionics
-
LSI Emerging Medtech Summit Will Spotlight 100 Innovative Startups to Audience of Investors & Strategic Partners
Life Science Intelligence (LSI) is hosting the Emerging Medtech Summit February 18-20th, 2020 at The Ritz-Carlton in Laguna Niguel, CA. The event is drawing attendance from major medtech investors and strategics looking to partner with new medical device, diagnostic, digital health and other healthtech innovators. In addition to startup CEO presentations, the event will include panel discussions ...
By Strados Labs
-
First Primary Total Knee Arthroplasty with the PEEK-OPTIMA Femoral Component
Maxx Orthopedics, in Partnership with Invibio Biomaterial Solutions, Announces First Primary Total Knee Arthroplasty with the PEEK-OPTIMA™ Femoral Component. Norristown, PA (USA) July 12, 2021: Maxx Orthopedics, Inc., and Invibio Biomaterial Solutions together announced the successful study initiation and first patients to be implanted with the new, all polymer, PEEK-OPTIMA™ femoral ...
-
ASTM F2042 - 00(2011) Standard Guide for Silicone Elastomers, Gels, and Foams Used in Medical Applications Part II—Crosslinking and Fabrication
This guide is intended to provide guidance for the specification and selection of fabrication methods for silicones used in medical devices. It also provides guidance relative to testing that might be done to qualify lots of acceptable material, based on desired performance properties. Silicone manufacturers supplying material ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you